Fiduciary Trust’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$520K Sell
3,080
-3,600
-54% -$616K 0.01% 563
2025
Q4
$1.13M Sell
6,680
-160
-2% -$26K 0.01% 391
2025
Q3
$987K Hold
6,840
0.01% 414
2025
Q2
$865K Sell
6,840
-75
-1% -$9.21K 0.01% 428
2025
Q1
$884K Hold
6,915
0.01% 413
2024
Q4
$914K Hold
6,915
0.01% 375
2024
Q3
$1.01M Sell
6,915
-121
-2% -$17.5K 0.01% 360
2024
Q2
$966K Sell
7,036
-12,973
-65% -$1.73M 0.01% 347
2024
Q1
$2.75M Buy
20,009
+40
+0.2% +$5.46K 0.04% 213
2023
Q4
$2.71M Sell
19,969
-5,240
-21% -$639K 0.05% 214
2023
Q3
$3.08M Sell
25,209
-2,600
-9% -$331K 0.06% 189
2023
Q2
$3.53M Sell
27,809
-7,920
-22% -$1.03M 0.06% 182
2023
Q1
$4.61M Sell
35,729
-3,344
-9% -$438K 0.09% 156
2022
Q4
$5.13M Buy
39,073
+12,106
+45% +$1.56M 0.1% 150
2022
Q3
$3.15M Sell
26,967
-794
-3% -$98.6K 0.07% 183
2022
Q2
$3.27M Sell
27,761
-2,987
-10% -$355K 0.07% 187
2022
Q1
$4.01M Sell
30,748
-3,246
-10% -$423K 0.07% 181
2021
Q4
$5.19M Sell
33,994
-437
-1% -$67.7K 0.09% 165
2021
Q3
$5.57M Buy
34,431
+696
+2% +$117K 0.1% 157
2021
Q2
$5.52M Sell
33,735
-332
-1% -$51.1K 0.11% 159
2021
Q1
$5.13M Sell
34,067
-300
-0.9% -$47.6K 0.1% 150
2020
Q4
$5.21M Buy
34,367
+1,035
+3% +$148K 0.11% 147
2020
Q3
$4.51M Buy
33,332
+3,832
+13% +$520K 0.11% 140
2020
Q2
$4.03M Sell
29,500
-332
-1% -$42.3K 0.1% 141
2020
Q1
$3.21M Hold
29,832
0.09% 147
2019
Q4
$3.6M Sell
29,832
-500
-2% -$55.8K 0.08% 152
2019
Q3
$3.02M Buy
30,332
+258
+0.9% +$27K 0.08% 163
2019
Q2
$3.28M Buy
30,074
+700
+2% +$74.5K 0.09% 157
2019
Q1
$3.28M Sell
29,374
-285
-1% -$31.3K 0.09% 150
2018
Q4
$2.86M Sell
29,659
-435
-1% -$46.2K 0.09% 150
2018
Q3
$3.67M Sell
30,094
-150
-0.5% -$17.7K 0.1% 147
2018
Q2
$3.32M Sell
30,244
-1,520
-5% -$163K 0.1% 156
2018
Q1
$3.39M Sell
31,764
-150
-0.5% -$16.6K 0.1% 150
2017
Q4
$3.41M Sell
31,914
-459
-1% -$49.1K 0.1% 151
2017
Q3
$3.6M Sell
32,373
-306
-0.9% -$32.7K 0.11% 141
2017
Q2
$3.38M Sell
32,679
-747
-2% -$73.6K 0.1% 145
2017
Q1
$3.27M Sell
33,426
-1,500
-4% -$144K 0.1% 145
2016
Q4
$3.09M Sell
34,926
-2,037
-6% -$185K 0.1% 154
2016
Q3
$3.57M Sell
36,963
-1,158
-3% -$110K 0.12% 137
2016
Q2
$3.27M Sell
38,121
-9,141
-19% -$820K 0.11% 144
2016
Q1
$4.11M Buy
47,262
+10,344
+28% +$925K 0.15% 130
2015
Q4
$4.16M Buy
36,918
+978
+3% +$106K 0.18% 114
2015
Q3
$3.63M Sell
35,940
-2,310
-6% -$277K 0.16% 116
2015
Q2
$4.7M Sell
38,250
-711
-2% -$85.1K 0.2% 109
2015
Q1
$4.46M Sell
38,961
-246
-0.6% -$27.1K 0.18% 113
2014
Q4
$3.96M Sell
39,207
-165
-0.4% -$16K 0.17% 116
2014
Q3
$3.59M Sell
39,372
-483
-1% -$42.4K 0.16% 119
2014
Q2
$3.41M Sell
39,855
-1,620
-4% -$128K 0.15% 123
2014
Q1
$3.27M Sell
41,475
-438
-1% -$36.5K 0.14% 125
2013
Q4
$3.17M Sell
41,913
-4,440
-10% -$315K 0.14% 124
2013
Q3
$3.24M Sell
46,353
-3,960
-8% -$259K 0.15% 117
2013
Q2
$2.92M Buy
+50,313
New +$2.91M 0.14% 120

Other funds holding IBB

Fiduciary Trust's IBB Position: Q1 2026 in Review

Fiduciary Trust reduced its iShares Biotechnology ETF (IBB) stake by 54% in Q1 2026, selling an estimated $616K and leaving 3,080 shares worth $520K. The position accounts for 0.01% of the portfolio, ranked #563.

Fiduciary Trust first reported a position in IBB in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.57M in Q3 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Fiduciary Trust held 3,080 shares of iShares Biotechnology ETF worth $520K as of Q1 2026.
  • Fiduciary Trust sold 3,600 iShares Biotechnology ETF shares in Q1 2026, an estimated $616K.
  • iShares Biotechnology ETF made up 0.01% of Fiduciary Trust's portfolio in Q1 2026, its #563 holding.
  • Fiduciary Trust first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 52 quarters since.
  • Fiduciary Trust's iShares Biotechnology ETF position peaked at $5.57M in Q3 2021.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Fiduciary Trust's 13F filing for Q1 2026, filed 15 May 2026.